4-Methyl-α-phenylbenzenemethanol is used in the synthesis of tropane analogs in the inhibition of binding at the dopamine transporter. Also is used in SAR studies relating to diphenylpiperazine N-type calcium channel inhibitors, analyzing their anti-hyperalgesic activity.